Team:Aachen/Achievements
From 2014.igem.org
(Difference between revisions)
(→Interlab study) |
(→Silver Requirements (4/4)) |
||
Line 80: | Line 80: | ||
# Documented the characterization of this part in the “Main Page” section of that Part’s/Device’s Registry entry. | # Documented the characterization of this part in the “Main Page” section of that Part’s/Device’s Registry entry. | ||
# Submitted this new part to the iGEM Parts Registry (submissions must adhere to the iGEM Registry guidelines). | # Submitted this new part to the iGEM Parts Registry (submissions must adhere to the iGEM Registry guidelines). | ||
- | # During the project we addressed several [https://2014.igem.org/Team:Aachen/PolicyPractices important questions beyond the bench]. Together with students of the [https://2014.igem.org/Team:Aachen/Collaborations/Kaiser-Karls-Gymnasium Kaiser-Karls-Gymnasium] and the [https://2014.igem.org/Team:Aachen/Collaborations/Neanderlab Gymnasiun am Neandertal] | + | # During the project we addressed several [https://2014.igem.org/Team:Aachen/PolicyPractices important questions beyond the bench]. Together with students of the [https://2014.igem.org/Team:Aachen/Collaborations/Kaiser-Karls-Gymnasium Kaiser-Karls-Gymnasium] and the [https://2014.igem.org/Team:Aachen/Collaborations/Neanderlab Gymnasiun am Neandertal] and people at the [https://2014.igem.org/Team:Aachen/Collaborations/MakerFaire MakerFaire] and the [https://2014.igem.org/Team:Aachen/Meetup iGEM Meetup] we discussed several issues regarding our project, microorganisms in our environment and synthetic biology. Since we use genetically engineered bacteria to detect human pathogens [https://2014.igem.org/Team:Aachen/Safety safety] was an important aspect for us throughout the whole project. Together with other german iGEM Teams we encountered an issue regarding [https://2014.igem.org/Team:Aachen/PolicyPractices/BioBrickIntellectualProperty intellectual property rights] in context of the legal status of Biobricks. |
Revision as of 13:16, 16 October 2014
|
|
|
|
|
|